Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,160,000 | 2,191,000 | 2,105,000 | 2,126,000 | 1,964,000 |
| Cost of Goods | 650,000 | 618,000 | 594,000 | 639,000 | 573,000 |
| Gross Profit | 1,510,000 | 1,573,000 | 1,511,000 | 1,487,000 | 1,391,000 |
| Operating Expenses | 1,146,000 | 1,433,000 | 1,163,000 | 1,821,000 | 1,098,000 |
| Operating Income | 364,000 | 140,000 | 348,000 | -334,000 | 293,000 |
| Interest Expense | 57,000 | 57,000 | 58,000 | 59,000 | 59,000 |
| Other Income | -2,000 | 6,000 | -33,000 | -4,000 | -6,000 |
| Pre-tax Income | 305,000 | 89,000 | 257,000 | -397,000 | 228,000 |
| Income Tax | 15,000 | -35,000 | 29,000 | -190,000 | 26,000 |
| Net Income Continuous | 290,000 | 124,000 | 228,000 | -207,000 | 202,000 |
| Net Income | $290,000 | $124,000 | $228,000 | $-207,000 | $202,000 |
| EPS Basic Total Ops | 0.21 | 0.09 | 0.17 | -0.15 | 0.15 |
| EPS Basic Continuous Ops | 0.21 | 0.09 | 0.17 | -0.15 | 0.15 |
| EPS Diluted Total Ops | 0.21 | 0.08 | 0.17 | -0.15 | 0.15 |
| EPS Diluted Continuous Ops | 0.21 | 0.09 | 0.17 | -0.15 | 0.15 |
| EBITDA(a) | $364,000 | $140,000 | $348,000 | $-334,000 | $293,000 |